Unknown NA INTERVENTIONAL 2-arm NCT02106637

Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS

Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Concomitant With Nurse-Led Support, in Patients After an Acute Coronary Syndrome (ACS)

Sponsor: Barzilai Medical Center

Conditions Acute Coronary Syndrome Smoking Cessation

Interventions Varenicline placebo

Updated 7 times since 2017 Last updated: Dec 4, 2017 Started: Oct 31, 2016 Primary completion: Aug 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Coronary Syndrome and Smoking Cessation, this trial is ongoing. The trial is conducted by Barzilai Medical Center and has accumulated 7 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2020 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Dec 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Dec 2017 [monthly]

Not Yet Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Barzilai Medical Center
Hadassah Medical Organization
Sheba Medical Center

Data source: Sheba Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ramat Gan, Israel